Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025
Value
£105,600
Suppliers
Classifications
- Pharmaceutical products
Tags
- award
Submission Deadline
7 months ago
Published
6 months ago
Description
Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Organisation
Timeline complete
Complete